Endometrial Cancer: Managing Toxicities in Lenvatinib and Pembrolizumab
Discover strategies for minimizing adverse events and overlapping toxicities in patients undergoing lenvatinib and pembrolizumab therapy for recurrent endometrial cancer.
Source: onclive.com